Idelara

Idelara Indications/Uses

letrozole

Manufacturer:

Craveri

Distributor:

Apolloplus Capital

Marketer:

Bioprofarma Bago
Full Prescribing Info
Indications/Uses
Letrozole (Idelara) is indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
Letrozole (Idelara) is indicated for the extended adjuvant treatment of early breast cancer in postmenopausal women, who have received 5 years of adjuvant tamoxifen therapy.
Letrozole (Idelara) is indicated for first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer.
Letrozole (Idelara) is indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in